Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 20 of 56

1.

The Lactobacillus Bile Salt Hydrolase Repertoire Reveals Niche-Specific Adaptation.

O'Flaherty S, Briner Crawley A, Theriot CM, Barrangou R.

mSphere. 2018 May 30;3(3). pii: e00140-18. doi: 10.1128/mSphere.00140-18. Print 2018 Jun 27.

2.

Functional microbiomics: Evaluation of gut microbiota-bile acid metabolism interactions in health and disease.

Mullish BH, Pechlivanis A, Barker GF, Thursz MR, Marchesi JR, McDonald JAK.

Methods. 2018 Apr 26. pii: S1046-2023(17)30422-X. doi: 10.1016/j.ymeth.2018.04.028. [Epub ahead of print]

PMID:
29704662
3.

Prevention of cholesterol gallstone disease by schaftoside in lithogenic diet-induced C57BL/6 mouse model.

Liu M, Liu C, Chen H, Huang X, Zeng X, Zhou J, Mi S.

Eur J Pharmacol. 2017 Nov 15;815:1-9. doi: 10.1016/j.ejphar.2017.10.003. Epub 2017 Oct 7.

PMID:
28993159
4.

Analyzing the hepatoprotective effect of the Swertia cincta Burkillextract against ANIT-induced cholestasis in rats by modulating the expression of transporters and metabolic enzymes.

Xu L, Sheng T, Liu X, Zhang T, Wang Z, Han H.

J Ethnopharmacol. 2017 Sep 14;209:91-99. doi: 10.1016/j.jep.2017.07.031. Epub 2017 Jul 19.

PMID:
28734962
5.

Physical Chemistry of Bile: Detailed Pathogenesis of Cholelithiasis.

Itani M, Dubinsky TJ.

Ultrasound Q. 2017 Sep;33(3):229-236. doi: 10.1097/RUQ.0000000000000287. Review.

PMID:
28350710
6.

Bile Duct Ligation Induces ATZ Globule Clearance in a Mouse Model of α-1 Antitrypsin Deficiency.

Khan Z, Yokota S, Ono Y, Bell AW, Oertel M, Stolz DB, Michalopoulos GK.

Gene Expr. 2017 Feb 10;17(2):115-127. doi: 10.3727/105221616X692991. Epub 2016 Aug 18.

7.

Liver - guardian, modifier and target of sepsis.

Strnad P, Tacke F, Koch A, Trautwein C.

Nat Rev Gastroenterol Hepatol. 2017 Jan;14(1):55-66. doi: 10.1038/nrgastro.2016.168. Epub 2016 Dec 7. Review.

PMID:
27924081
8.

Serum Plant Sterols Associate with Gallstone Disease Independent of Weight Loss and Non-Alcoholic Fatty Liver Disease.

Käkelä P, Männistö V, Ilves I, Vaittinen M, Tauriainen MM, Eskelinen M, Gylling H, Paajanen H, Pihlajamäki J.

Obes Surg. 2017 May;27(5):1284-1291. doi: 10.1007/s11695-016-2446-z.

PMID:
27812789
9.

[Effect of vinegar-processed Curcumae Rhizoma on bile metabolism in rats].

Gu W, Lu TL, Li JC, Wang QH, Pan ZH, Ji, Li L, Zhang J, Mao CQ.

Zhongguo Zhong Yao Za Zhi. 2016 Apr;41(7):1318-1324. doi: 10.4268/cjcmm20160726. Chinese.

PMID:
28879750
10.

Expanding role of gut microbiota in lipid metabolism.

Ghazalpour A, Cespedes I, Bennett BJ, Allayee H.

Curr Opin Lipidol. 2016 Apr;27(2):141-7. doi: 10.1097/MOL.0000000000000278. Review.

11.

Role of Nutraceuticals in Hypolipidemic Therapy.

Barbagallo CM, Cefalù AB, Noto D, Averna MR.

Front Cardiovasc Med. 2015 May 11;2:22. doi: 10.3389/fcvm.2015.00022. eCollection 2015. Review.

12.

Ursodeoxycholic Acid Inhibits Clostridium difficile Spore Germination and Vegetative Growth, and Prevents the Recurrence of Ileal Pouchitis Associated With the Infection.

Weingarden AR, Chen C, Zhang N, Graiziger CT, Dosa PI, Steer CJ, Shaughnessy MK, Johnson JR, Sadowsky MJ, Khoruts A.

J Clin Gastroenterol. 2016 Sep;50(8):624-30. doi: 10.1097/MCG.0000000000000427.

14.

Metabolism of bile with respect to etiology of gallstone disease - systematic review.

Pasternak A, Szura M, Gil K, Brzozowska I, Maduzia D, Mizia E, Walocha K, Matyja A.

Folia Med Cracov. 2014;54(2):5-16. Review.

15.

The FXR agonist obeticholic acid prevents gut barrier dysfunction and bacterial translocation in cholestatic rats.

Verbeke L, Farre R, Verbinnen B, Covens K, Vanuytsel T, Verhaegen J, Komuta M, Roskams T, Chatterjee S, Annaert P, Vander Elst I, Windmolders P, Trebicka J, Nevens F, Laleman W.

Am J Pathol. 2015 Feb;185(2):409-19. doi: 10.1016/j.ajpath.2014.10.009. Epub 2015 Jan 12.

PMID:
25592258
16.

Bile metabolism and lithogenesis.

O'Connell K, Brasel K.

Surg Clin North Am. 2014 Apr;94(2):361-75. doi: 10.1016/j.suc.2014.01.004. Epub 2014 Feb 18. Review.

PMID:
24679426
17.

T-cell factor 4 and β-catenin chromatin occupancies pattern zonal liver metabolism in mice.

Gougelet A, Torre C, Veber P, Sartor C, Bachelot L, Denechaud PD, Godard C, Moldes M, Burnol AF, Dubuquoy C, Terris B, Guillonneau F, Ye T, Schwarz M, Braeuning A, Perret C, Colnot S.

Hepatology. 2014 Jun;59(6):2344-57. doi: 10.1002/hep.26924. Epub 2014 Apr 14.

PMID:
24214913
18.

Integrative analysis of proteomic and transcriptomic data for identification of pathways related to simvastatin-induced hepatotoxicity.

Cho YE, Moon PG, Lee JE, Singh TS, Kang W, Lee HC, Lee MH, Kim SH, Baek MC.

Proteomics. 2013 Apr;13(8):1257-75. doi: 10.1002/pmic.201200368.

PMID:
23322611
19.

Perinatal gene transfer to the liver.

McKay TR, Rahim AA, Buckley SM, Ward NJ, Chan JK, Howe SJ, Waddington SN.

Curr Pharm Des. 2011;17(24):2528-41. Review.

20.

A promoter polymorphism in the liver-specific fatty acid transport protein 5 is associated with features of the metabolic syndrome and steatosis.

Auinger A, Valenti L, Pfeuffer M, Helwig U, Herrmann J, Fracanzani AL, Dongiovanni P, Fargion S, Schrezenmeir J, Rubin D.

Horm Metab Res. 2010 Nov;42(12):854-9. doi: 10.1055/s-0030-1267186. Epub 2010 Oct 13.

PMID:
20945272

Supplemental Content

Loading ...
Support Center